Detected ·

Beeline Medicines

——

Beeline Medicines raised $300M in Series A from Bain Capital (sole investor). Clinical-stage biotech building mechanistically guided therapies for autoimmune and inflammatory diseases, anchored by a lupus program.

Amount
—
Stage
—
Event
Funding round
Detected
2026-04-16 09:11:19 UTC
Signal ID
1160cfaa-d68a-4776-a654-45e3ad77323f

As the API returns it

{
  "id": "1160cfaa-d68a-4776-a654-45e3ad77323f",
  "created_at": "2026-04-16T09:11:19.920447Z",
  "company_name": "Beeline Medicines",
  "company_website_url": "www.beelinemedicines.com",
  "company_linkedin_url": "https://www.linkedin.com/company/beelinemedicines",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Beeline Medicines raised $300M in Series A from Bain Capital (sole investor). Clinical-stage biotech building mechanistically guided therapies for autoimmune and inflammatory diseases, anchored by a lupus program.*"
}

Latest rounds